Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Viruses with RNA Genomes01:29

Viruses with RNA Genomes

358
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
358
Viral Recombination00:57

Viral Recombination

24.4K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
24.4K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

48.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
48.3K
Retroviruses02:33

Retroviruses

13.4K
Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
13.4K
Subviral Agents01:29

Subviral Agents

288
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
288
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

688
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
688

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune-related adverse event profiles and survival outcomes in non-small cell lung cancer: a cluster analysis from a long-term real-world study.

Respiratory research·2026
Same author

LAR/NMLR stratify mortality risk before and after checkpoint inhibitor pneumonitis in NSCLC: multi-state and time-dependent analyses.

BMC cancer·2026
Same author

Antagonism of stress granules key for SARS-CoV-2 infection and pathogenesis.

bioRxiv : the preprint server for biology·2026
Same author

Mitochondrial Transport in Bone Metabolism Homeostasis: Molecular Mechanisms and Targeted Therapeutic Strategies.

International journal of molecular sciences·2026
Same author

Imbalanced mitochondrial fusion/fission in human placenta: a potential link to preeclampsia.

Scientific reports·2026
Same author

[Clinical efficacy evaluation and economic analysis of regulating-<i>yinyang</i> moxibustion therapy for primary dysmenorrhea of cold induced blood stasis: a randomized controlled trial].

Zhongguo zhen jiu = Chinese acupuncture & moxibustion·2026

Related Experiment Video

Updated: Nov 14, 2025

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

831

A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence.

Xianwen Zhang1, Yang Liu1, Jianying Liu2

  • 1Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA.

Cell
|March 10, 2021
PubMed
Summary
This summary is machine-generated.

Researchers developed a safe method to study severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in BSL-2 labs. This system produces single-round infectious virus, enabling high-throughput research and antiviral testing without BSL-3 containment.

Keywords:
COVID-19SARS-CoV-2antiviralcoronavirusdiagnosisvaccine

More Related Videos

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.1K
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

59.4K

Related Experiment Videos

Last Updated: Nov 14, 2025

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro
09:26

Production of a SARS-CoV-2 Virus-Like-Particle System to Investigate Viral Life Cycles In Vitro

Published on: June 6, 2025

831
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.1K
Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on: March 1, 2019

59.4K

Area of Science:

  • Virology
  • Molecular Biology
  • Infectious Diseases

Background:

  • The high biosafety level 3 (BSL-3) requirement for culturing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents a significant obstacle for extensive research and drug development.
  • Developing safe and efficient methods to study SARS-CoV-2 is crucial for understanding its pathogenesis and creating effective countermeasures.

Purpose of the Study:

  • To establish a trans-complementation system for generating single-round infectious SARS-CoV-2.
  • To enable high-throughput neutralization and antiviral testing of SARS-CoV-2 in a BSL-2 laboratory setting.
  • To provide a safer alternative to traditional BSL-3 culture methods for SARS-CoV-2 research.

Main Methods:

  • A two-component trans-complementation system was engineered, comprising a modified genomic viral RNA with specific gene deletions and a producer cell line expressing the deleted genes.
  • The system generates virions capable of a single round of infection in naive cells, preventing the production of wild-type SARS-CoV-2.
  • In vivo safety was assessed by inoculating hamsters and K18-hACE2 transgenic mice with the complementation-derived virions.

Main Results:

  • The trans-complementation system successfully produced single-round infectious SARS-CoV-2 that recapitulated authentic viral replication.
  • These engineered virions could be safely utilized in BSL-2 laboratories for neutralization and antiviral assays.
  • Animal studies involving hamsters and K18-hACE2 transgenic mice showed no detectable disease following inoculation with the complementation-derived virions, even at high doses.

Conclusions:

  • The developed trans-complementation platform offers a safe and effective method for studying SARS-CoV-2 in BSL-2 environments.
  • This system significantly reduces the biosafety bottleneck, facilitating high-throughput research and the development of novel antiviral strategies.
  • The findings support the broader application of this platform for accelerating SARS-CoV-2 countermeasure development.